Interferon alpha with nucleoside analog

This page covers all Interferon alpha with nucleoside analog drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Interferon-alpha receptor (IFNAR); HCV RNA-dependent RNA polymerase, Interferon-alpha receptor (IFNAR); viral RNA-dependent RNA polymerase.

Targets

Interferon-alpha receptor (IFNAR); HCV RNA-dependent RNA polymerase · Interferon-alpha receptor (IFNAR); viral RNA-dependent RNA polymerase

Marketed (2)

• Peginterferon alfa-2a with Ribavirin · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Virology/Hepatology
  Peginterferon alfa-2a activates interferon-alpha receptors to enhance antiviral immunity, while ribavirin inhibits viral RNA synthesis, together suppressing hepatitis C virus replication.
• Peginterferon alfa-2a 40KD and Ribavirin · NORDynamIC Study Group · Virology / Hepatology
  Peginterferon alfa-2a activates interferon-alpha receptors to enhance antiviral immunity, while ribavirin inhibits viral RNA synthesis, together suppressing hepatitis C virus replication.

Phase 3 pipeline (1)

• Peginterferon a-2a plus Ribavirin · Hepatitis Resource Network · Virology / Hepatology
  Peginterferon alfa-2a activates interferon-alpha receptors to enhance antiviral immunity, while ribavirin inhibits viral RNA synthesis, together suppressing hepatitis C virus replication.